Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Armstrong

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|October 18, 2018
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trialsR G Langley, A W Armstrong, M G Lebwohl, et al.
The British Journal of Dermatology|November 29, 2018
Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studiesK Reich, K A Papp, A W Armstrong, et al.
Epidemiology and Infection|April 8, 2011
Genetic diversity and antibiotic resistance in Shigella dysenteriae and Shigella boydii strains isolated from children aged <5 years in EgyptA M El-Gendy, A Mansour, M A Weiner, et al.
The British Journal of Dermatology|December 17, 2020
Words matter: a randomized controlled study evaluating the impact of decision-framing on treatment preferences in adults with psoriasis and psoriatic arthritisA A Kassardjian, V S Chat, L Archuleta, et al.
Journal of the National Cancer Institute|September 16, 1992
Environmental tobacco smoke and lung cancer risk in nonsmoking womenH G Stockwell, A L Goldman, G H Lyman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2017
Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)N H Shear, R Alhusayen, A Fernandez-Obregon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 4, 2022
Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis FoundationD M W Balak, L M Perez-Chada, L N Guo, et al.
The British Journal of Dermatology|November 10, 2019
Defining drug-free remission of skin disease in patients with plaque psoriasisA W Armstrong, A Blauvelt, J J Crowley, et al.
Journal of Psoriasis and Psoriatic Arthritis|December 27, 2023
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic DiseaseA C Gustafson, J M Gelfand, J Davies, et al.
The British Journal of Dermatology|June 9, 2021
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2K Reich, K B Gordon, B E Strober, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|October 18, 2018
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trialsR G Langley, A W Armstrong, M G Lebwohl, et al.
The British Journal of Dermatology|November 29, 2018
Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studiesK Reich, K A Papp, A W Armstrong, et al.
Epidemiology and Infection|April 8, 2011
Genetic diversity and antibiotic resistance in Shigella dysenteriae and Shigella boydii strains isolated from children aged <5 years in EgyptA M El-Gendy, A Mansour, M A Weiner, et al.
The British Journal of Dermatology|December 17, 2020
Words matter: a randomized controlled study evaluating the impact of decision-framing on treatment preferences in adults with psoriasis and psoriatic arthritisA A Kassardjian, V S Chat, L Archuleta, et al.
Journal of the National Cancer Institute|September 16, 1992
Environmental tobacco smoke and lung cancer risk in nonsmoking womenH G Stockwell, A L Goldman, G H Lyman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2017
Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)N H Shear, R Alhusayen, A Fernandez-Obregon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 4, 2022
Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis FoundationD M W Balak, L M Perez-Chada, L N Guo, et al.
The British Journal of Dermatology|November 10, 2019
Defining drug-free remission of skin disease in patients with plaque psoriasisA W Armstrong, A Blauvelt, J J Crowley, et al.
Journal of Psoriasis and Psoriatic Arthritis|December 27, 2023
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic DiseaseA C Gustafson, J M Gelfand, J Davies, et al.
The British Journal of Dermatology|June 9, 2021
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2K Reich, K B Gordon, B E Strober, et al.
Pageof 4